Cargando…

Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns

OBJECTIVE: Neoantigens derived from tumor-specific genomic alterations have demonstrated great potential for immunotherapeutic interventions in cancers. However, the comprehensive profile of hepatocellular carcinoma (HCC) neoantigens and their complex interplay with immune microenvironment and tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhenli, Chen, Geng, Cai, Zhixiong, Dong, Xiuqing, He, Lei, Qiu, Liman, Zeng, Yongyi, Liu, Xiaolong, Liu, Jingfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286898/ https://www.ncbi.nlm.nih.gov/pubmed/34321833 http://dx.doi.org/10.21147/j.issn.1000-9604.2021.03.08

Ejemplares similares

Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
por: Cai, Zhixiong, et al.
Publicado: (2021)

Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report
por: Zeng, Yongyi, et al.
Publicado: (2020)

Circular RNA profiling identifies circADAMTS13 as a miR‐484 sponge which suppresses cell proliferation in hepatocellular carcinoma
por: Qiu, Liman, et al.
Publicado: (2019)

Personalized neoantigen vaccine combined with PD-1 blockade increases CD8(+) tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models
por: Chen, Hengkai, et al.
Publicado: (2022)

Copy number profiling of circulating free DNA predicts transarterial chemoembolization response in advanced hepatocellular carcinoma
por: Dong, Xiuqing, et al.
Publicado: (2022)

Cytosolic Delivery of Thiolated Neoantigen Nano‐Vaccine Combined with Immune Checkpoint Blockade to Boost Anti‐Cancer T Cell Immunity
por: Zhang, Da, et al.
Publicado: (2021)

Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
por: Wu, Ming, et al.
Publicado: (2023)

Genomic and Transcriptomic Landscape of Tumor Clonal Evolution in Cholangiocarcinoma
por: Chen, Geng, et al.
Publicado: (2020)

Circular RNA CircEPB41L2 Functions as Tumor Suppressor in Hepatocellular Carcinoma Through Sponging miR-590-5p
por: Chen, Feng, et al.
Publicado: (2021)

Dysregulation of global circular RNA abundance regulated by spliceosomes predicts prognosis in hepatocellular carcinoma
por: He, Lei, et al.
Publicado: (2022)

Accurate transcriptome assembly by Nanopore RNA sequencing reveals novel functional transcripts in hepatocellular carcinoma
por: Fang, Yuanchang, et al.
Publicado: (2021)

Identification of tumor mutations in plasma based on mutation variant frequency change (MVFC)
por: Chen, Geng, et al.
Publicado: (2023)

Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification
por: Ke, Kun, et al.
Publicado: (2018)

Remodeling Tumor‐Associated Neutrophils to Enhance Dendritic Cell‐Based HCC Neoantigen Nano‐Vaccine Efficiency
por: Wang, Yunhao, et al.
Publicado: (2022)

Galectin-4 serves as a prognostic biomarker for the early recurrence / metastasis of hepatocellular carcinoma
por: Cai, Zhixiong, et al.
Publicado: (2014)

Quantitative proteomics analysis of early recurrence/metastasis of huge hepatocellular carcinoma following radical resection
por: Huang, Xinhui, et al.
Publicado: (2014)

Caveolin-mediated cytosolic delivery of spike nanoparticle enhances antitumor immunity of neoantigen vaccine for hepatocellular carcinoma
por: Lin, Zhiwen, et al.
Publicado: (2023)

Role of exosomes in hepatocellular carcinoma cell mobility alteration
por: Wang, Sen, et al.
Publicado: (2017)

The hepatectomy efficacy of huge hepatocellular carcinoma and its risk factors: A meta analysis
por: Wang, Lei, et al.
Publicado: (2017)

Tumor Microenvironment Activable Self‐Assembled DNA Hybrids for pH and Redox Dual‐Responsive Chemotherapy/PDT Treatment of Hepatocellular Carcinoma
por: Zhang, Da, et al.
Publicado: (2017)

α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC
por: Xu, Bo, et al.
Publicado: (2014)

Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma
por: Wang, Chao, et al.
Publicado: (2021)

Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma
por: Fang, Guoxu, et al.
Publicado: (2022)

The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection
por: Liu, Hongzhi, et al.
Publicado: (2019)

Neoantigens as potential vaccines in hepatocellular carcinoma
por: Repáraz, David, et al.
Publicado: (2022)

Exploiting Autophagy-Dependent Neoantigen Presentation in Tumor Microenvironment
por: Koustas, Evangelos, et al.
Publicado: (2023)

Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization
por: Ke, Qiao, et al.
Publicado: (2021)

Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
por: Chen, Pu, et al.
Publicado: (2021)

Identification of Clonal Neoantigens Derived From Driver Mutations in an EGFR-Mutated Lung Cancer Patient Benefitting From Anti-PD-1
por: Wu, Di, et al.
Publicado: (2020)

Dataset for the quantitative proteomics analysis of the primary hepatocellular carcinoma with single and multiple lesions
por: Xing, Xiaohua, et al.
Publicado: (2015)

Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas
por: Yu, Guangyang, et al.
Publicado: (2021)

Polydopamine-assisted versatile modification of a nucleic acid probe for intracellular microRNA imaging and enhanced photothermal therapy
por: Zheng, Aixian, et al.
Publicado: (2018)

Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming
por: Liang, Yuanzheng, et al.
Publicado: (2022)

Development and Validation of a Machine Learning Prognostic Model for Hepatocellular Carcinoma Recurrence After Surgical Resection
por: Huang, Yao, et al.
Publicado: (2021)

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
por: Löffler, Markus W., et al.
Publicado: (2019)

NeoFox: annotating neoantigen candidates with neoantigen features
por: Lang, Franziska, et al.
Publicado: (2021)

Scoring model based on the signature of non-m6A-related neoantigen-coding lncRNAs assists in immune microenvironment analysis and TCR-neoantigen pair selection in gliomas
por: Zhao, Wenbo, et al.
Publicado: (2022)

Prognosis Factors of Young Patients Undergoing Curative Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Multicenter Study
por: Zeng, Jianxing, et al.
Publicado: (2020)

Lymphoma neoantigens
por: Elias, Joshua E.
Publicado: (2018)

The Role of Neoantigens in Cancer Immunotherapy
por: Zhu, Yueting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vonao69nft0pibjof4dkb79t9e